Optimizing Steroid Therapy and Ensuring Medication Access in Duchenne Muscular Dystrophy

Effective management of Duchenne muscular dystrophy (DMD) requires balancing the benefits of corticosteroids with their potential side effects. Best practices include individualized dosing strategies, careful monitoring of growth, weight, behavior, and bone health, and considering alternative regimens such as weekend or low-dose schedules when appropriate. Regular assessments and open communication with patients and caregivers help tailor therapy to minimize adverse effects while maintaining functional benefits. Ensuring medication access is equally critical, as timely initiation and adherence directly impact outcomes. Clinicians often collaborate closely with insurance providers and pharmaceutical manufacturers, leveraging prior authorizations, patient assistance programs, and clear documentation of medical necessity. Coordinated efforts across clinical, administrative, and patient-support teams streamline access, reduce delays, and ensure continuity of care. Combining optimized dosing with proactive access strategies helps maximize therapeutic benefits and supports long-term management of DMD.